Mithra Pharmaceuticals S.A.
MITPF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $28 | $33 | $139 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $36 | $55 | $17 | $57 |
| Inventory | $48 | $50 | $44 | $35 |
| Other Curr. Assets | $0 | $12 | $6 | $8 |
| Total Curr. Assets | $93 | $146 | $99 | $238 |
| Property Plant & Equip (Net) | $51 | $106 | $108 | $99 |
| Goodwill | $5 | $5 | $5 | $5 |
| Intangibles | $109 | $140 | $110 | $94 |
| Long-Term Investments | $16 | $24 | $32 | $33 |
| Tax Assets | $0 | $16 | $63 | $51 |
| Other NC Assets | $12 | $4 | $4 | $1 |
| Total NC Assets | $193 | $297 | $323 | $284 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $287 | $442 | $422 | $522 |
| Liabilities | – | – | – | – |
| Payables | $59 | $32 | $17 | $23 |
| Short-Term Debt | $33 | $70 | $71 | $43 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $3 | $1 | $2 | $1 |
| Other Curr. Liab. | $9 | $28 | $7 | $3 |
| Total Curr. Liab. | $104 | $130 | $96 | $71 |
| LT Debt | $179 | $176 | $168 | $285 |
| Deferred Rev, NC | $0 | $8 | $13 | $19 |
| Deferred Tax Liab, NC | $0 | $4 | $6 | $4 |
| Other NC Liab. | $107 | $90 | $106 | -$15 |
| Total NC Liab. | $286 | $278 | $292 | $294 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $38 | $43 | $49 | $52 |
| Total Liabilities | $390 | $409 | $388 | $364 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $51 | $41 | $32 | $31 |
| Retained Earnings | -$589 | -$396 | -$337 | -$220 |
| AOCI | $11 | -$20 | -$3 | $14 |
| Other Equity | $425 | $409 | $341 | $333 |
| Total Equity | -$103 | $34 | $34 | $158 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $287 | $442 | $422 | $522 |
| Net Debt | $203 | $218 | $205 | $190 |